Arterra Bioscience is an Italian green biotech company specializing in research and development in biotechnology, listed on the EGM since 2019, releases FY 2022 results.

Our equity research confirms the BUY and reduces the Target Price to €4.5

Find out why in the analysis by Francesca Romana Sabatini Head of Equity Research.

Download the search here